The FOXC1, MSX1, IPO7, and ZHX2 regulatory pathway of HL should thus be further explored; subsequent experiments that determine the molecular mechanisms through which FOXC1 dysregulates ZHX2 as well as other components that operate within the pathway would help develop specific methods to hinder increased HL aggression. This evidence concerns the gene IPO7 and Hodgkins lymphoma.